Pharmaste Daily: October 14, 2026

Go to the current selection →

DAILY SELECTION · October 14, 2026

Question focus: Biostatistics. Drug cards rotate across medication classes.

QUESTION OF THE DAY

Make a choice. Understand the why.

Loading saved progress…

QUESTION 1 OF 1

Strategy A costs $25,000 and yields 4.5 QALYs; Strategy B costs $15,000 and yields 4.0 QALYs. What is the ICER for A vs B?

Choose one best answer.

Educational practice. Your latest submitted response is saved when you are logged in. An unsent answer is not saved. Practice results do not predict exam readiness.

Continue with biostatistics →

DRUG OF THE DAY

metformin

Biguanide antihyperglycemic

Before opening the card, recall one use, one safety check and one counseling point.

Reveal the drug learning card

Names and formulations

  • Metformin hydrochloride: immediate-release oral tablet
  • Glumetza: extended-release oral tablet

Immediate-release and extended-release tablets differ in dosing and administration; ER tablets should be swallowed whole and may leave a soft shell in stool.

Common use

Improves glycemic control in type 2 diabetes alongside diet and exercise.

Mechanism of action

Reduces hepatic glucose production, decreases intestinal glucose absorption, and improves insulin sensitivity.

Important adverse effects and monitoring

  • Boxed warning: metformin-associated lactic acidosis is rare but serious; risk rises with severe kidney impairment, hypoxic states, liver impairment, and excessive alcohol use.
  • Assess eGFR before initiation and periodically; initiation is not recommended at eGFR 30–45 mL/min/1.73 m² and use is contraindicated below 30.
  • Monitor vitamin B12 periodically, especially with anemia, neuropathy, or long-term therapy.

Patient counseling

  • Take with meals to reduce gastrointestinal effects; swallow ER tablets whole.
  • Avoid excessive alcohol and tell the radiology team about metformin before iodinated-contrast procedures.

Interaction to recognize

With: carbonic anhydrase inhibitors such as topiramate

Why it matters: Can increase acidosis risk.

Practical response: Consider more frequent monitoring and reassess symptoms or kidney function when combined.

Check the original sources

Selected learning points; verify current labeling for the complete prescribing information.

Featured from our existing free, reviewed collections. Revisit a concept as it returns in the rotation. Featuring a resource today does not change its original source-check date.

Browse past selections →